Informations générales (source: ClinicalTrials.gov)
SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours (BIOPORTAL)
Interventional
N/A
Institut Curie (Voir sur ClinicalTrials)
novembre 2023
novembre 2038
29 juin 2024
The SIOPEN BIOPORTAL is a prospective non-therapeutic multi-centre international study
aimed at developing an international Registry linked to a Virtual Biobank for all the
patients with peripheral neuroblastic tumor within countries of the SIOPEN network. The
overall aim of this study is to provide a GDPR-compliant framework to collect basic
clinical annotations, biological and genetic features and information about the location
on biospecimens for all the patients with a peripheral neuroblastic tumor including
neuroblastoma, ganglioneuroblastoma and ganglioneuroma in the SIOPEN network.
This study will support data and sample management and intensify cross-borders data and
sample sharing fostering translational and clinical research. The post-hoc hypothesis
formulated based on the data generated in this study will be used as statistical basis
for future precision medicine programs based on improved biological characterization,
patient stratification and therapeutic management.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT CURIE | 04/12/2024 12:44:14 | Contact (sur clinicalTrials) | |||
| CLCC INSTITUT GUSTAVE ROUSSY | Nathalie GASPAR | 24/05/2024 09:45:47 | Contacter | ||
| Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| AP-HP - Hôpital Armand Trousseau-La Roche Guyon | Contact (sur clinicalTrials) | ||||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Léon Bérard - 69373 - Lyon - France | Contact (sur clinicalTrials) | ||||
| Centre Oscar Lambret - 59020 - Lille - France | Contact (sur clinicalTrials) | ||||
| Chr Nantes - 44093 - Nantes - France | Contact (sur clinicalTrials) | ||||
| Chru Brest - 29609 - Brest - France | Contact (sur clinicalTrials) | ||||
| CHU Amiens - 80054 - Amiens - France | Contact (sur clinicalTrials) | ||||
| Chu Angers - 49033 - Angers - France | Contact (sur clinicalTrials) | ||||
| CHU CAEN - Fédération de cancérologie - niveau 21 - 14033 - Caen - France | Contact (sur clinicalTrials) | ||||
| CHU D'Estaing de CLERMONT FERRAND - 63003 - Clermont-Ferrand - France | Contact (sur clinicalTrials) | ||||
| Chu Grenoble - 38045 - Grenoble - France | Contact (sur clinicalTrials) | ||||
| Chu Hopital Sud - 35056 - Rennes - France | Contact (sur clinicalTrials) | ||||
| CHU NANCY- Hôpital d'Enfants - 54500 - Vandœuvre-lès-Nancy - France | Contact (sur clinicalTrials) | ||||
| CHU NICE - 06202 - Nice - France | Contact (sur clinicalTrials) | ||||
| Chu Reims - 51092 - Reims - France | Contact (sur clinicalTrials) | ||||
| DIJON Hôpital d'enfants - 21079 - Dijon - France | Contact (sur clinicalTrials) | ||||
| Hôpital Arnaud de Villeneuve - 34295 - Montpellier - France | Contact (sur clinicalTrials) | ||||
| Hôpital Charles NICOLLE - 76031 - Rouen - France | Contact (sur clinicalTrials) | ||||
| Hôpital Clocheville - 37044 - Tours - France | Contact (sur clinicalTrials) | ||||
| Hôpital d'Enfants de la Timone - 13385 - Marseille - France | Contact (sur clinicalTrials) | ||||
| Hôpital des enfants - 33076 - Bordeaux - France | Contact (sur clinicalTrials) | ||||
| Hôpital des Enfants - 70034 - Toulouse - France | Contact (sur clinicalTrials) | ||||
| Hôpital Hautepierre-CHU Strasbourg - 67098 - Strasbourg - France | Contact (sur clinicalTrials) | ||||
| Hôpital Jean Bernard - 86021 - Poitiers - France | Contact (sur clinicalTrials) | ||||
| Hôpital Jean Minjoz - 25030 - Besançon - France | Contact (sur clinicalTrials) | ||||
| Hôpital Nord - 42055 - Saint-Étienne - France | Contact (sur clinicalTrials) | ||||
Critères
Tous
Inclusion Criteria:
I-1. Patients with PNT: ganglioneuroma or ganglioneuroblastoma or neuroblastoma, I-2. At
the time of initial diagnosis of neuroblastic tumour, or at relapse/progression if not
yet registered I-3. Written patient informed consent, or parents or legal representative
written informed consent and assent of the child, adolescent or young adult
Non-Inclusion Criteria:
R-1. (Adult) Patients with olfactory neuroblastoma R-2. Central nervous system (CNS)
neuroblastoma (as per the WHO classification)
I-1. Patients with PNT: ganglioneuroma or ganglioneuroblastoma or neuroblastoma, I-2. At
the time of initial diagnosis of neuroblastic tumour, or at relapse/progression if not
yet registered I-3. Written patient informed consent, or parents or legal representative
written informed consent and assent of the child, adolescent or young adult
Non-Inclusion Criteria:
R-1. (Adult) Patients with olfactory neuroblastoma R-2. Central nervous system (CNS)
neuroblastoma (as per the WHO classification)